Creatine Monohydrate Supplementation Safety in Healthy Adults
Creatine monohydrate supplementation is considered safe in healthy adults without renal, hepatic, or metabolic disease based on available short- to medium-term human data and position statements summarizing that evidence. [1],[2] Reported renal effects are limited to increases in serum creatinine with no observed adverse change in measured or inferred kidney filtration markers in controlled trials. [1],[2],[3]
Safety Profile for Renal Function
Creatine supplementation is associated with a modest increase in serum creatinine that is not consistently accompanied by deterioration in glomerular filtration rate markers in clinical studies. [2],[3] A double-blind, placebo-controlled randomized clinical trial using renal biomarker approaches found creatine supplementation did not adversely affect renal function in healthy adults. [3] A systematic review and meta-analysis of randomized trials found no adverse effect of creatine supplementation on glomerular filtration rate and concluded that creatine does not adversely affect renal outcomes despite creatinine changes. [2]
Safety Profile for Hepatic Function
Creatine supplementation has not demonstrated clinically meaningful adverse effects on liver enzymes in available human studies summarized in a sports nutrition position stand. [1] In a systematic review and meta-analysis focused on female participants, no evidence of negative creatine effects on liver function was found in that dataset. [4]
Safety Profile for Cardiometabolic and Other Outcomes
Available evidence in healthy populations summarized by a sports nutrition position stand indicates no consistent adverse health risks across multiple organ-system and laboratory safety domains during study durations up to several years. [1] Structured review and dose–response analyses of randomized controlled trials report no increase in overall side effects, including renal and hepatic adverse events, at study-level dosing and durations studied. [5]
Dosing Ranges Used in Safety Data
Safety evidence includes regimens commonly used to increase or maintain muscle creatine stores, including loading strategies around 0.3 g/kg/day for several days followed by maintenance dosing in healthy adults. [1] Trials and reviews also include longer durations with substantially higher cumulative exposure than typical maintenance dosing, without clinically significant renal, hepatic, or hematologic abnormalities in the summarized evidence. [1]
Clinical Use Clarifications
Serum creatinine increases during creatine supplementation should be interpreted cautiously because creatine can raise creatinine via non–kidney filtration mechanisms, which can confound interpretation of creatinine-only assessments. [2] Renal safety assessments should rely on filtration markers beyond serum creatinine when feasible, including trials that use renal biomarker panels or validated filtration assessments. [2],[3]
Evidence Limitations
Long-term randomized controlled trial evidence extending beyond about one year remains limited for definitive exclusion of rare adverse renal outcomes in the general healthy adult population. [6] Most safety data come from controlled supplementation studies in physically active cohorts, which may not fully represent all demographic and comorbidity profiles. [1],[6]
Practical Safety Conclusion for a Healthy Adult Without Renal, Hepatic, or Metabolic Disease
Creatine monohydrate supplementation at commonly studied doses is supported by position-statement and trial-level evidence as safe for renal filtration function, with the main predictable laboratory change being a modest rise in serum creatinine without demonstrated kidney injury in controlled studies. [1],[2],[3] Hepatic safety signals have not been demonstrated in human evidence summaries and meta-analyses in populations without baseline liver disease. [1],[4]